Advertisement

Topics

World Federation of Hemophilia (WFH) Company Profile

06:52 EDT 22nd September 2018 | BioPortfolio

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963, it is a global network of patient organizations in 113 countries and has official recognition from the World Health Organization. Visit WFH online at www.wfh.org.


News Articles [527 Associated News Articles listed on BioPortfolio]

Roche to present new phase III data for Hemlibra in people with haemophilia A at the World Federation of Hemophilia 2018 World Congress

Roche today announced that phase III results for Hemlibra® (emicizumab) will be presented for the first time during the World Federation of Hemophilia (WFH) 2018 World Congress from 20-24 May in Glas...

Genentech’s Hemlibra Significantly Reduces Bleeding in Late-Stage Hemophilia Studies

Genentech’s hemophilia treatment Hemlibra continues to demonstrate its efficacy in treating patients. New late-stage data presented at World Federation of Hemophilia 2018 World Congress shows the dr...

Roche's hemophilia drug outperforms in clinical trials

Two clinical studies presented at the World Federation of Hemophilia congress in Glasgow, Scotland, showed that Roche Holding -More- 

Catalyst Biosciences Announces Oral Presentation at the World Federation of Hemophilia 2018 World Congress

SOUTH SAN FRANCISCO, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address h...

Data Could Make Roche Drug a Hemophilia Standard, But for How Long?

It’s been a bumpy ride for emicizumab (Hemlibra) in 2018. The Roche/Genentech drug, approved by the FDA in late 2017, has a chance to become the choice treatment for people with hemophilia A, and ne...

Five Deaths in Genentech's Hemlibra Patients

The Hemophilia Federation of America and the National Hemophilia Foundation announced that they had been contacted by Genentech, a Roche company, about the deaths of five patients receiving Hemlibra (...

Invitation to Roche’s Virtual Pipeline Event from WFH 2018 World Congress

We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Wednesday, 23 May 2018, from the World Federation of Hemophilia (WFH) 2018 World Congress ...

Reminder: Invitation to Roche’s Virtual Pipeline Event from WFH 2018 World Congress

We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Wednesday, 23 May 2018, from the World Federation of Hemophilia (WFH) 2018 World Congress ...

PubMed Articles [1124 Associated PubMed Articles listed on BioPortfolio]

rFIXFc for Immune Tolerance Induction in a Severe Hemophilia B Patient with an Inhibitor and Prior History of ITI Related Nephrotic Syndrome.

Miracle of haemophilia drugs: Personal views about a few main players.

In the second decade of the third millennium there have been dramatic developments pertaining to the availability of highly innovative drugs for hemophilia care, notwithstanding a satisfactory previou...

Factor XI and pulmonary infections.

Value of prophylaxis vs on-demand treatment: Application of a value framework in hemophilia.

Therapeutic advances over the past 30 years have led to longer life expectancy and improved quality of life (QOL) for persons with hemophilia. Access to innovative therapy may be compromised if treat...

Replacement therapy during surgery in von Willebrand disease needs personalization.

Clinical Trials [1529 Associated Clinical Trials listed on BioPortfolio]

World Bleeding Disorders Registry

The World Federation of Hemophilia (WFH) is conducting the pilot phase of an international, retrospective and prospective, observational, World Bleeding Disorders Registry (WBDR). This pil...

ATHN 7: Hemophilia Natural History Study

This is a real-world study of the safety of the treatments used for people with hemophilia. The study will follow people with hemophilia A or B from across the country for about 4 years as...

World Bleeding Disorders Registry

The WBDR is an international observational disease registry of patients with hemophilia. It will provide a platform for a network of hemophilia treatment centres (HTCs) around the world to...

Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry: A Nested Study Within an Existing Registry

This US study aims to assess hemophilia A patient characteristics and reasons for switching from both patient/caregiver and physician perspectives. For this purpose, this research study wi...

Study Evaluating ReFacto in Hemophilia A

To identify the causative mutations in previously untreated patients with hemophilia A enrolled in the ReFacto® clinical safety and efficacy study CTN 93-R833-0XX/C9741-28, using two esta...

Companies [718 Associated Companies listed on BioPortfolio]

World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963,...

World Federation of Hemophilia

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and other inherited bleeding di...

Hemophilia Federation of America

NORSK INDUSTRI

On 28. November 2005 the new organisation Federation of Norwegian Industries was established. The new Federation will be formally operative as of 1. January 2006. From the start, the Federation of Nor...

World Heart Federation

The World Congress of Cardiology Scientific Sessions is the official congress of the World Heart Federation and is held every two years. Through the Congress the World Heart Federation offers an inter...

More Information about "World Federation of Hemophilia (WFH)" on BioPortfolio

We have published hundreds of World Federation of Hemophilia (WFH) news stories on BioPortfolio along with dozens of World Federation of Hemophilia (WFH) Clinical Trials and PubMed Articles about World Federation of Hemophilia (WFH) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of World Federation of Hemophilia (WFH) Companies in our database. You can also find out about relevant World Federation of Hemophilia (WFH) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record